Logansport Medical Center Professional C is categorized under Doctors in Logansport, IN and active since 2001.
Logansport Medical Center Professional C was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Dr Ruben A Calisto at the company’s single location by writing to 2708 Elmwood Drive, Logansport, Indiana IN 46947 or by phoning (574) 753-3865. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Logansport Medical Center Professional C |
| Contact Person: | Dr Ruben A Calisto |
| Address: | 2708 Elmwood Drive, Logansport, Indiana 46947 |
| Phone Number: | (574) 753-3865 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2001 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Logansport Medical Center Professional C was started in 2001 to provide professional Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Dr Ruben A Calisto for inquiries that concern Logansport Medical Center Professional C by calling the company number (574) 753-3865, as your correspondence is most welcome. Additionally, the physical location of the single location of Logansport Medical Center Professional C can be found at the coordinates 40.771462,-86.332765 as well as the street address 2708 Elmwood Drive in Logansport, Indiana 46947.
For its online presence, you may visit Logansport Medical Center Professional C’s website at and engage with its social media outlets through on Twitter and on Facebook.